128 related articles for article (PubMed ID: 27828697)
1. Aripiprazole-Induced Hyperlipidemia: An Update.
Tarraf C; Naja WJ
Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828697
[TBL] [Abstract][Full Text] [Related]
2. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.
Citrome L; Kalsekar I; Baker RA; Hebden T
Curr Med Res Opin; 2014 Aug; 30(8):1629-41. PubMed ID: 24666104
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
McIntyre RS
Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews.
Ribeiro ELA; de Mendonça Lima T; Vieira MEB; Storpirtis S; Aguiar PM
Eur J Clin Pharmacol; 2018 Oct; 74(10):1215-1233. PubMed ID: 29905899
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
7. Clozapine-induced hyperlipidemia resolved after switch to aripiprazole therapy.
Ball MP; Hooper ET; Skipwith DF; Cates ME
Ann Pharmacother; 2005 Sep; 39(9):1570-2. PubMed ID: 16046490
[TBL] [Abstract][Full Text] [Related]
8. Drug safety evaluation of aripiprazole in bipolar disorder.
Cuomo A; Beccarini Crescenzi B; Goracci A; Bolognesi S; Giordano N; Rossi R; Facchi E; Neal SM; Fagiolini A
Expert Opin Drug Saf; 2019 Jun; 18(6):455-463. PubMed ID: 31072228
[No Abstract] [Full Text] [Related]
9. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice.
Cuomo A; Goracci A; Fagiolini A
J Affect Disord; 2018 Mar; 228():229-237. PubMed ID: 29275156
[TBL] [Abstract][Full Text] [Related]
10. Obsessive-Compulsive Symptoms Associated With Aripiprazole Treatment in Bipolar Disorder: A Case Report.
Gupta P; Gupta R; Balhara YP
J Clin Psychopharmacol; 2017 Feb; 37(1):108-109. PubMed ID: 27930496
[No Abstract] [Full Text] [Related]
11. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
[TBL] [Abstract][Full Text] [Related]
12. A clinical study of the association of antipsychotics with hyperlipidemia.
de Leon J; Susce MT; Johnson M; Hardin M; Pointer L; Ruaño G; Windemuth A; Diaz FJ
Schizophr Res; 2007 May; 92(1-3):95-102. PubMed ID: 17346932
[TBL] [Abstract][Full Text] [Related]
13. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
14. [Aripiprazole, gambling disorder and compulsive sexuality].
Mété D; Dafreville C; Paitel V; Wind P
Encephale; 2016 Jun; 42(3):281-3. PubMed ID: 26923999
[TBL] [Abstract][Full Text] [Related]
15. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.
Wisniewski CS; Robert S
Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346
[TBL] [Abstract][Full Text] [Related]
16. Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder.
Woo YS; Bahk WM; Park YM; Chung S; Yoon BH; Won S; Lee JG; Lee HB; Kim W; Jeong JH; Lee K; Kim MD
Int Clin Psychopharmacol; 2016 Sep; 31(5):275-86. PubMed ID: 27487259
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis.
Bernagie C; Danckaerts M; Wampers M; De Hert M
CNS Drugs; 2016 Sep; 30(9):807-18. PubMed ID: 27395403
[TBL] [Abstract][Full Text] [Related]
18. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.
Arbaizar B; Dierssen-Sotos T; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2009; 31(5):478-83. PubMed ID: 19703642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]